Insights on Nefecon®, a Targeted-Release Formulation of Budesonide and Its Selective Immunomodulatory Effects in Patients with IgA Nephropathy
-
Published:2024-07
Issue:
Volume:Volume 18
Page:3415-3428
-
ISSN:1177-8881
-
Container-title:Drug Design, Development and Therapy
-
language:en
-
Short-container-title:DDDT
Author:
Barratt JonathanORCID,
Kristensen Jens,
Pedersen Christian,
Jerling MarkusORCID
Publisher
Informa UK Limited